Notice of Sole-Source for Rhapsody Application Implementation Enhancements
Award Notice Posted
- Solicitation number
- 75F40120A00010_75F40124F19006_Notice
- Agency
- Not on record
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75F40120A00010-75F40124F19006_P00002
- NAICS code
- 541519 Other Computer Related Services
- Place of performance
- Rockville, Maryland 20850, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration, operating under the Department of Health and Human Services, awarded a sole-source modification to Deloitte Consulting LLP on May 12, 2026, increasing the value of BPA Call 75F40124F19006 by $2,635,113.62 for Rhapsody application implementation enhancements supporting tobacco marketing regulatory review.
The modification was issued under GSAM/R 538.7104-3(b)(1)(iii) as a logical follow-on to the original FSS order, which was competitively awarded on September 29, 2024, against GSA Federal Supply Schedule contract GS-35F-0617Y. The work falls within Task Area 8 (Development, Modernization, and Enhancements) and specifically supports requirements gathering, analysis, development, implementation, and ongoing support for targeted Rhapsody use-cases assisting in regulatory review of tobacco products marketing applications such as PMTA Acceptance Review. The contract is structured as time-and-materials, labor-hour pricing. The current period of performance expires in September 2026, with an option to extend through March 2027. The modification brings the total not-to-exceed value to $18,560,183.43 with a potential obligation of $1,993,147.50. Deloitte Consulting LLP is located at 1919 N Lynn Street, Arlington, VA 22209-1742.
Notice text
This is a notice of award on a sole source basis, issued in accordance with the regulation at GSAR 538.7104-3(b)(3)(ii). The U.S. Department of Health and Human Services (HHS) has modified BPA Call 75F40124F19006, originally issued against the Blanket Purchase Agreement (BPA) 75F40120A00010 which was established by the U.S. Food and Drug Administration (FDA) under the GSA Federal Supply Schedule (FSS) contract GS-35F-0617Y with the following entity:
Deloitte Consulting LLP
1919 N Lynn St
Arlington, VA 22209-1742
The purpose of this modification is to provide additional support for requirements gathering and analysis, development, implementation, and ongoing support of targeted data for Rhapsody use-cases designed to assist in the regulatory review of tobacco marketing applications (e.g. PMTA Acceptance Review). The work provided as a result of this modification falls within the technical scope of the original requirement: Specifically, Task Area 8, Development, Modernization, and Enhancements (DME) and 8.1.2, Functional Enhancements as outlined in the contract's original Statement of Work.
In the interest of economy and efficiency, the new work is a logical follow-on to an original order in accordance with GSAM/R 538.7104-3(b)(1)(iii).
Awarded contract 75F40120A00010 to DELOITTE CONSULTING LLP for 21195297.05 on 2026-05-12.
Files
| File | Type | Posted |
|---|---|---|
| Rhapsody SSJ under FAR part 8_Redacted.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity